{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:46:57Z","timestamp":1790830017504,"version":"4.1.0"},"reference-count":43,"publisher":"Portland Press Ltd.","issue":"11","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Aim: The study aims to evaluate protective effects of sophoricoside (Sop) on cardiac hypertrophy. Meanwhile, the potential and significance of Sop should be broadened and it should be considered as an attractive drug for the treatment of pathological cardiac hypertrophy and heart failure.<\/jats:p>\n               <jats:p>Methods: Using the phenylephrine (PE)-induced neonatal rat cardiomyocytes (NRCMs) enlargement model, the potent protection of Sop against cardiomyocytes enlargement was evaluated. The function of Sop was validated in mice received transverse aortic coarctation (TAC) or sham surgery. At 1 week after TAC surgery, mice were treated with Sop for the following 4 weeks, the hearts were harvested after echocardiography examination.<\/jats:p>\n               <jats:p>Results: Our study revealed that Sop significantly mitigated TAC-induced heart dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis. Mechanistically, Sop treatment induced a remarkable activation of AMPK\/mTORC1-autophagy cascade following sustained hypertrophic stimulation. Importantly, the protective effect of Sop was largely abolished by the AMPK\u03b1 inhibitor Compound C, suggesting an AMPK activation-dependent manner of Sop function on suppressing pathological cardiac hypertrophy.<\/jats:p>\n               <jats:p>Conclusion: Sop ameliorates cardiac hypertrophy by activating AMPK\/mTORC1-mediated autophagy. Hence, Sop might be an attractive candidate for the treatment of pathological cardiac hypertrophy and heart failure.<\/jats:p>","DOI":"10.1042\/bsr20200661","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T11:46:59Z","timestamp":1600861619000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Sophoricoside ameliorates cardiac hypertrophy by activating AMPK\/mTORC1-mediated autophagy"],"prefix":"10.1042","volume":"40","author":[{"given":"Maomao","family":"Gao","sequence":"first","affiliation":[{"name":"Medical Research Institute, Wuhan University, Wuhan 430072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Hu","sequence":"additional","affiliation":[{"name":"Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Hu","sequence":"additional","affiliation":[{"name":"Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Shi","sequence":"additional","affiliation":[{"name":"Institute of Model Animal of Wuhan University, Luojia Mount Wuchang, Wuhan 430072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongshu","family":"Jian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Xiao","family":"Ji","sequence":"additional","affiliation":[{"name":"Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"She","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-0297","authenticated-orcid":false,"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Research Institute, Wuhan University, Wuhan 430072, China"},{"name":"Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China"},{"name":"Institute of Model Animal of Wuhan University, Luojia Mount Wuchang, Wuhan 430072, China"},{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"},{"name":"Basic Medical School, Wuhan University, Wuhan 430071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Model Animal of Wuhan University, Luojia Mount Wuchang, Wuhan 430072, China"},{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2021111620284976700_B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cphy.c140055.","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"2021111620284976700_B2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"2021111620284976700_B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"2021111620284976700_B4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"2021111620284976700_B5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.molmed.2010.12.003","article-title":"The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart","volume":"17","author":"Doroudgar","year":"2011","journal-title":"Trends Mol. Med."},{"key":"2021111620284976700_B6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/abbs\/gmw025","article-title":"The role of autophagy in cardiac hypertrophy","volume":"48","author":"Li","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"2021111620284976700_B7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021111620284976700_B8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10741-010-9166-6","article-title":"Role of autophagy in heart failure associated with aging","volume":"15","author":"De Meyer","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"2021111620284976700_B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yjmcc.2015.11.019","article-title":"Therapeutic targeting of autophagy in cardiovascular disease","volume":"95","author":"Schiattarella","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"2021111620284976700_B10","doi-asserted-by":"publisher","first-page":"H304","DOI":"10.1152\/ajpheart.00145.2017","article-title":"Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy","volume":"313","author":"Wang","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021111620284976700_B11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/1750-3841.14047","article-title":"Hepatoprotective effects of Sophoricoside against fructose-induced liver injury via regulating lipid metabolism, oxidation, and inflammation in mice","volume":"83","author":"Li","year":"2018","journal-title":"J. Food Sci."},{"key":"2021111620284976700_B12","doi-asserted-by":"publisher","first-page":"15624","DOI":"10.3390\/molecules181215624","article-title":"Modulation of lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes by sophoricoside","volume":"18","author":"Wu","year":"2013","journal-title":"Molecules"},{"key":"2021111620284976700_B13","doi-asserted-by":"publisher","first-page":"181905","DOI":"10.1098\/rsos.181905 30800407","article-title":"New crystal forms and amorphous phase of sophoricoside: X-ray structures and characterization","volume":"6","author":"Xing","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"2021111620284976700_B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.intimp.2013.01.025","article-title":"Sophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-kappaB signaling in B cells","volume":"15","author":"Lee","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"2021111620284976700_B15","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.3390\/molecules18056113","article-title":"The ameliorative effect of sophoricoside on mast cell-mediated allergic inflammation in vivo and in vitro","volume":"18","author":"Kim","year":"2013","journal-title":"Molecules"},{"key":"2021111620284976700_B16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/HYPERTENSIONAHA.116.07420","article-title":"Type III transforming growth factor-\u03b2 receptor drives cardiac hypertrophy through \u03b2-arrestin2\u2013dependent activation of calmodulin-dependent protein kinase II","volume":"68","author":"Lou","year":"2016","journal-title":"Hypertension"},{"key":"2021111620284976700_B17","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/ncomms4303","article-title":"IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat. Commun."},{"key":"2021111620284976700_B18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.113.02653","article-title":"Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy","volume":"63","author":"Jiang","year":"2014","journal-title":"Hypertension"},{"key":"2021111620284976700_B19","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1038\/ncomms11267","article-title":"The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling","volume":"7","author":"Ji","year":"2016","journal-title":"Nat. Commun."},{"key":"2021111620284976700_B20","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.1073\/pnas.1008397107","article-title":"Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111620284976700_B21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","article-title":"Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy","volume":"61","author":"Jiang","year":"2013","journal-title":"Hypertension"},{"key":"2021111620284976700_B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000491664","article-title":"Nuclear localization leucine-rich-repeat protein 1 deficiency protects against cardiac hypertrophy by pressure overload","volume":"48","author":"Zong","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"2021111620284976700_B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2021111620284976700_B24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"2021111620284976700_B25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11427-017-9197-5","article-title":"AMPK and cardiac remodelling","volume":"61","author":"Feng","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"2021111620284976700_B26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12885-019-5458-y","article-title":"Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"},{"key":"2021111620284976700_B27","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3390\/ijms20225543","article-title":"A double negative feedback loop between mTORC1 and AMPK kinases guarantees precise autophagy induction upon cellular stress","volume":"20","author":"Holczer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2021111620284976700_B28","first-page":"2423","article-title":"Mitochondrial dysfunction induced by excessive ROS\/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention","volume":"36","author":"Zhang","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"2021111620284976700_B29","first-page":"865","article-title":"Study of cardiovascular and cerebrovascular disease in Chinese traditional medicines on Pb, Cr, Cd by AAS","volume":"21","author":"Zhang","year":"2001","journal-title":"Guang Pu Xue Yu Guang Pu Fen Xi"},{"key":"2021111620284976700_B30","first-page":"133","article-title":"The hormonal effect of an isoflavone derivative (sophoricoside)","volume":"13","author":"Gabor","year":"1961","journal-title":"Kiserl Orvostud."},{"key":"2021111620284976700_B31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/nu8120754","article-title":"Soy and health update: evaluation of the clinical and epidemiologic literature","volume":"8","author":"Messina","year":"2016","journal-title":"Nutrients"},{"key":"2021111620284976700_B32","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.3892\/mmr.2018.9544","article-title":"Formononetin may protect aged hearts from ischemia\/reperfusion damage by enhancing autophagic degradation","volume":"6","author":"Huang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"2021111620284976700_B33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/ijms17081318","article-title":"Anti-atherosclerotic effects of a phytoestrogen-rich herbal preparation in postmenopausal women","volume":"17","author":"Myasoedova","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"2021111620284976700_B34","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.jid.2016.04.017","article-title":"Roseotoxin B improves allergic contact dermatitis through a unique anti-inflammatory mechanism involving excessive activation of autophagy in activated T lymphocytes","volume":"136","author":"Wang","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"2021111620284976700_B35","first-page":"515","article-title":"Apoptosis, autophagy & endoplasmic reticulum stress in diabetes mellitus","volume":"144","author":"Demirtas","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"2021111620284976700_B36","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1111\/jcmm.14172","article-title":"Type 2 diabetes is associated with suppression of autophagy and lipid accumulation in beta-cells","volume":"23","author":"Ji","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"2021111620284976700_B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/HMER.S98120","article-title":"Autophagy: a new target for nonalcoholic fatty liver disease therapy","volume":"8","author":"Mao","year":"2016","journal-title":"Hepat. Med."},{"key":"2021111620284976700_B38","first-page":"632","article-title":"Autophagy and nonalcoholic fatty liver disease","volume":"24","author":"Li","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"2021111620284976700_B39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7150\/ijbs.14213","article-title":"Asiatic acid protects against cardiac hypertrophy through activating AMPKalpha signalling pathway","volume":"12","author":"Ma","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"2021111620284976700_B40","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/bph.13449","article-title":"Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor\/AMPKalpha signalling pathway","volume":"173","author":"Ma","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"2021111620284976700_B41","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/mnfr.201300012","article-title":"Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-alpha","volume":"57","author":"Deng","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"2021111620284976700_B42","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur. Heart J."},{"key":"2021111620284976700_B43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S2213-8587(14)70241-4","article-title":"Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial","volume":"3","author":"Axelsson","year":"2015","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200661\/897718\/bsr-2020-0661.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200661\/897718\/bsr-2020-0661.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:56:33Z","timestamp":1637096193000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/11\/BSR20200661\/226492\/Sophoricoside-ameliorates-cardiac-hypertrophy-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,27]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20200661","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,11]]},"article-number":"BSR20200661"}}